Cliff Asness’s Abeona Therapeutics ABEO Stock Holding History
Bought
Maintained
Sold
Other funds holding ABEO
NCM
CCC
ACM
OIA
AIC
KCM
Cliff Asness's ABEO Position: Q2 2026 in Review
Cliff Asness reduced its Abeona Therapeutics (ABEO) stake by 35% in Q2 2026, selling an estimated $195K and leaving 67,063 shares worth $414K. The position accounts for ﹤0.01% of the portfolio, ranked #3475.
Cliff Asness first reported a position in ABEO in Q3 2017 and has held it in 14 quarters since. The position peaked at $750K in Q3 2017. 126 funds tracked by Wall St. Rank hold ABEO as of Q2 2026.
- Cliff Asness held 67,063 shares of Abeona Therapeutics worth $414K as of Q2 2026.
- Cliff Asness sold 35,582 Abeona Therapeutics shares in Q2 2026, an estimated $195K.
- Abeona Therapeutics made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #3475 holding.
- Cliff Asness first reported a position in Abeona Therapeutics in Q3 2017 and has held it in 14 quarters since.
- Cliff Asness's Abeona Therapeutics position peaked at $750K in Q3 2017.
- 126 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2026.
Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.